The Federal Office for Competition Regulation (Bkarta) is intensifying its focus on Germany’s electricity market, aiming to address the persistently high prices faced by consumers. This initiative was confirmed by Andreas Mundt, president of the Bkarta, in a recent announcement.
According to Mundt, the agency has been “continuously and closely monitoring price formation on the electricity market.” He noted that recent challenges, such as operating with a reduced fleet of power plants for the first time this winter, have led to significant fluctuations in electricity prices. While these variations could reflect a natural market outcome, the agency plans to keep a vigilant eye on price trends in the coming months and intervene if necessary.
Periods of “dark pauses,” where renewable energy sources like solar and wind are unavailable due to conditions such as nighttime or a lack of wind, are a particular area of concern. Per the statement from Mundt, these dark pauses can create gaps in energy production, potentially leading to spikes in electricity prices.
The Federal Network Agency, Germany’s energy regulator, is also stepping up its oversight. It recently announced plans to examine any “evidence of abusive behavior on electricity prices during dark pauses.” This additional scrutiny complements the work of the Bkarta and highlights the government’s commitment to ensuring fair market practices in the energy sector.
Source: Agenzia Nova
Featured News
Norton Rose Adds Antitrust Partners in Italy
Jan 20, 2025 by
CPI
Antitrust Lawsuit Over Google’s Search Monopoly Proceeds in CA Court
Jan 20, 2025 by
CPI
Digital Markets Act at Two Years: Enforcement in a Shifting Political Climate
Jan 20, 2025 by
CPI
EU Expands Tech Oversight with Updated Anti-Hate Speech Code
Jan 20, 2025 by
CPI
Cargill Settles Turkey Price-Fixing Lawsuit for $32.5 Million
Jan 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
CPI
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
CPI
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
CPI